NBW Capital’s Bristol-Myers Squibb BMY Stock Holding History

NBW Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,380	Closed	-$206K	–	113
2025 Q1	$206K	Buy	+3,380	New	+$197K	0.05%	98
2023 Q4	–	Sell	-3,819	Closed	-$222K	–	108
2023 Q3	$222K	Sell	3,819 -302	-7%	-$18.5K	0.05%	96
2023 Q2	$264K	Buy	4,121 +470	+13%	+$31.5K	0.06%	89
2023 Q1	$253K	Buy	3,651 +530	+17%	+$37.4K	0.06%	91
2022 Q4	$225K	Buy	+3,121	New	+$235K	0.06%	92
2022 Q2	–	Sell	-2,881	Closed	-$210K	–	85
2022 Q1	$210K	Buy	+2,881	New	+$193K	0.05%	84

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NBW Capital's BMY Position: Q2 2025 in Review

NBW Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,380 shares — an estimated $206K sold.

NBW Capital first reported a position in BMY in Q1 2022 and held it in 6 quarters. The position peaked at $264K in Q2 2023. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

NBW Capital reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
NBW Capital sold 3,380 Bristol-Myers Squibb shares in Q2 2025, an estimated $206K.
NBW Capital first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 6 quarters.
NBW Capital's Bristol-Myers Squibb position peaked at $264K in Q2 2023.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.